Multiple myeloma is a plasma-cell cancer causing bone destruction, anaemia, recurrent infections, renal dysfunction, and hypercalcemia. It presents with bone pain, fractures, fatigue, weight loss, and ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...

At the American Society of Hematology Conference in Orlando, new results from the MajesTEC-3 study show that combining ...

When patients and families first hear the words multiple myeloma, they often ask: how is this different from other cancers? Myeloma is a blood cancer that behaves unlike tumors you can see or ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer ...

Bruce Springsteen and Patti Scialfa have been married since 1991. (Photo by Michael Buckner/Golden Globes 2024/Golden Globes 2024 via Getty Images) “This affects my immune system, so I have to be ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...

Emphasis on accessible, low-toxicity treatments, including oral therapies, to reduce financial burden and improve patient ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...

Regeneron's new antibody drug, Lynozyfic, shows promise in eradicating residual multiple myeloma without the need for bone marrow transplants, according to a small mid-stage trial. The treatment ...